Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J.B. Møller
Pdb22 - Clinical and Demographic Characteristics of Patients Reaching a High Daily Dose of Ideglira Six Months After Initiation in a Real-World Setting
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pdb17 - Real-World Dosing Behaviours and Outcomes When Switching to Ideglira From a Free Combination of Insulin and Glucagon-Like Peptide-1 Receptor Agonist Therapy
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Demographic, Clinical and Microbiological Characteristics of Maternity Patients: A Canadian Clinical Cohort Study
Canadian Journal of Infectious Diseases
Clinical and Demographic Profile of Catatonic Patients Who Received Electroconvulsive Therapy in a South African Setting
South African Journal of Psychiatry
Psychiatry
Mental Health
Dose Increase Beyond Labelled Dose of Biologic Treatments in Psoriasis Patients: A Real-World Study in Sweden
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Large‐Scale, Prospective Observational Study of Regorafenib in Japanese Patients With Metastatic Colorectal Cancer in a Real‐World Clinical Setting
Oncologist
Cancer Research
Medicine
Oncology
Evaluation of Demographic and Clinical Characteristics of Patients With Mucopolysaccharidosis
The Journal of Pediatric Research
Demographic and Clinical Characteristics of Patients in Private Hospital Dermatology Clinic
Turkiye Klinikleri Journal of Medical Sciences
Medicine
Association Among Nursing Diagnoses, Demographic Variables, and Clinical Characteristics of Patients With High Blood Pressure
ACTA Paulista de Enfermagem
Surgical Nursing
Medical
Specialized Nursing
Advanced
Tolerability and Discontinuation Rates in Teriflunomide-Treated Patients. A Real-World Clinical Experience
Neurosciences
Psychiatry
Mental Health
Neurology
Efficacy of Natalizumab and Fingolimod in Relapsing Remitting Multiple Sclerosis in Real World Clinical Setting
Journal of Neurology & Neurophysiology
